The Anaqua AQX Pharma™ IP Management platform is a specialized version of Anaqua's flagship AQX® platform, built to address the unique intellectual property (IP) needs of pharmaceutical and life science companies. It empowers organizations to focus on the statutory and business relationships between IP assets (patents, trademarks, licenses) and the drug products they protect throughout the entire lifecycle.
Key capabilities are designed to maximize market exclusivity, improve decision-making, and increase profitability. The platform features tools for managing product-to-IP lifecycle relationships via visual dashboards and enables strategic decision-making by providing a clear view of upcoming patent and product deadlines, including Patent Term Extensions (PTE) and Supplemental Protection Certificates (SPC) on a worldwide basis. A critical feature is the integration of US FDA Orange Book data and analytics, which helps fulfill statutory reporting requirements with less risk and automates the process of tracking Loss of Exclusivity.
Furthermore, AQX Pharma provides robust financial insights, allowing users to track and forecast IP expenses and generate IP contribution revenue reports by drug and country. The platform is a secure, SaaS solution that integrates with essential enterprise systems like matter management, financial systems, Document Management Systems (DMS), and HR systems via its API-based AQX Sync solution. It is trusted by large and medium-sized pharmaceutical companies globally, helping IP executives, attorneys, paralegals, administrators, and innovators streamline operations and turn IP into a strategic advantage.